Page last updated: 2024-11-04

linsidomine and Glaucoma

linsidomine has been researched along with Glaucoma in 1 studies

linsidomine: RN given refers to parent cpd; structure

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acharya, S1
Rogers, P1
Krishnamoorthy, RR1
Stankowska, DL1
Dias, HV1
Yorio, T1

Other Studies

1 other study available for linsidomine and Glaucoma

ArticleYear
Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy.
    Bioorganic & medicinal chemistry letters, 2016, Mar-01, Volume: 26, Issue:5

    Topics: Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Glaucoma; Humans; Hydrogen

2016